Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines (Q37922124)

25 August 2017

1 reference

title

Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines (English)

1 reference

25 August 2017

1 reference

Fulvio Stacul

1

1 reference

25 August 2017

Aart J van der Molen

2

1 reference

25 August 2017

Peter Reimer

3

1 reference

25 August 2017

Judith A W Webb

4

1 reference

25 August 2017

Henrik S Thomsen

5

1 reference

25 August 2017

Sameh K Morcos

6

1 reference

25 August 2017

Torsten Almén

7

1 reference

25 August 2017

Peter Aspelin

8

1 reference

25 August 2017

Marie-France Bellin

9

1 reference

25 August 2017

Olivier Clement

10

1 reference

25 August 2017

Gertraud Heinz-Peer

11

1 reference

25 August 2017

Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR)

12

1 reference

25 August 2017

language of work or name

English

0 references

publication date

25 August 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

21

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

2527-2541

1 reference

Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Improving outcomes of acute kidney injury: report of an initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Contrast-induced nephropathy and long-term adverse events: cause and effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Creatinine kinetics and the definition of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Background fluctuation of kidney function versus contrast-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Risk markers for contrast-induced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

In which patients should serum creatinine be measured before iodinated contrast medium administration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Serious renal dysfunction after percutaneous coronary interventions can be predicted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Contrast-induced nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Multiple myeloma and contrast media

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Contrast-induced nephropathy after intravenous administration: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Incidence and outcomes of contrast-induced AKI following computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Staging of chronic kidney disease: time for a course correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Estimated glomerular filtration rate: time for a performance review?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Nephrotoxic effects in high-risk patients undergoing angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chroni

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Prevention of contrast-induced nephropathy: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Strategies to reduce the risk of contrast-induced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Prevention of contrast-induced nephropathy with volume expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Acetylcysteine and contrast agent-associated nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

N-acetylcysteine in the prevention of contrast-induced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Prophylaxis strategies for contrast-induced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Evidence-based emergency medicine review. Prevention of contrast-induced nephropathy in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

N-Acetylcysteine does not artifactually lower plasma creatinine concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

The Prevention of Radiocontrast-Agent–Induced Nephropathy by Hemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

An overview of drug-induced acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Gadolinium-containing contrast media for radiographic examinations: a position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Safety of gadolinium contrast angiography in patients with chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

The safety of gadolinium in patients with stage 3 and 4 renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Incidence of lactic acidosis in metformin users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Comparative outcomes study of metformin intervention versus conventional approach the COSMIC Approach Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Kidney function and age are both predictors of pharmacokinetics of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Re-evaluation of a biguanide, metformin: mechanism of action and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Contraindications can damage your health--is metformin a case in point?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Nephrotoxicity of high-dose gadolinium compared with iodinated contrast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2225-0

Use of intravenous contrast agents in patients receiving metformin

21 January 2018

1 reference

12 December 2020

The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency

1 reference

12 December 2020

Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Comparison of iodixanol and iohexol in renal impairment

1 reference

12 December 2020

Prevention of contrast-induced nephropathy: a critical review.

1 reference

12 December 2020

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

1 reference

12 December 2020

Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality

1 reference

12 December 2020

Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies

1 reference

12 December 2020

Why we should sub-divide CKD stage 3 into early (3a) and late (3b) components

1 reference

12 December 2020

What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?

1 reference

12 December 2020

Metformin and contrast media

1 reference

12 December 2020

Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study.

1 reference

12 December 2020

Effect on renal function of an iso-osmolar contrast agent in patients with monoclonal gammopathies

1 reference

12 December 2020

What is the best definition of contrast-induced nephropathy?

1 reference

12 December 2020

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine

1 reference

12 December 2020

Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations

1 reference

12 December 2020

Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction

1 reference

12 December 2020

Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings?

1 reference

12 December 2020

Establishing pragmatic estimated GFR thresholds to guide metformin prescribing

1 reference

12 December 2020

A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media

1 reference

12 December 2020

Effectiveness of acetylcysteine in prevention of contrast nephropathy

1 reference

12 December 2020

Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease

1 reference

12 December 2020

A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity

1 reference

12 December 2020

The potential role of statins in contrast nephropathy.

1 reference

12 December 2020

A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation

1 reference

12 December 2020

A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients

1 reference

12 December 2020

Improving Outcomes from Acute Kidney Injury

1 reference

12 December 2020

Are gadolinium-based contrast media nephrotoxic? A renal biopsy study

1 reference

12 December 2020

Renal effects of gadopentetate dimeglumine in patients with normal and impaired renal function.

1 reference

12 December 2020

Epidemiology of contrast-induced nephropathy

1 reference

12 December 2020

Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media

1 reference

12 December 2020

PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction

1 reference

12 December 2020

Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary

1 reference

12 December 2020

Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial

1 reference

12 December 2020

Drug-induced nephrotoxicity

1 reference

12 December 2020

The global burden of chronic kidney disease: how valid are the estimates?

1 reference

12 December 2020

Dialysis and contrast media

1 reference

12 December 2020

Formula-based estimates of the GFR: equations variable and uncertain

1 reference

12 December 2020

Prevention of contrast media-induced nephrotoxicity after angiographic procedures

1 reference

12 December 2020

Gadolinium-based contrast media may be nephrotoxic even at approved doses

1 reference

12 December 2020

10.1007/S00330-011-2225-0

Identifiers

DOI

1 reference

25 August 2017

1 reference